3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Interventions
pembrolizumab
2
Ipilimumab
2
Axitinib
2
fludarabine
1
Specimen Handling
1
Selenomethionine
1
Radiopharmaceuticals
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Inulin
1
CTLA-4 Antigen
1
Biopsy
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Clear-cell metastatic renal cell carcinoma
×
Radiopharmaceuticals
×
Clear all
NCT06059014
2026-04-24
PRadR
Centre Leon Berard
Phase 1/2
Completed
6 enrolled